Regulatory Aspects of Acute Neurotoxicity Assessment

Hayes' Handbook of Pesticide Toxicology

Volumn , Issue , 2010, Pages 587-602

  Allen, Sandra L ^a  

^a Regulatory Science Associates   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856948991     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374367-1.00020-3     Document Type: Chapter

References (110)

1. Albee R.R., Mattsson J.L., Yano B.L., Chang L.W. Neurobehavioural effects of dietary restriction in rats. Neurotoxicol. Teratol. 1987, 9:203-211.
2. Alder S., Zbinden G. Methods in the evaluation of physical, neuromuscular and behavioral development of rats in early postnatal life. Methods in Prenatal Toxicology 1977, 175-185. Thieme, Stuttgart, Germany. D. Neubert, H.J. Merker, T.E. Kwasigroch (Eds.).
3. Alder S., Zbinden G. Neurobehavioral tests in single and repeated-dose toxicity studies in small rodents. Arch. Toxicol. 1983, 54:1-23.
4. Anger K.W., Jordan M.K., Lynch D.W. Effects of inhalation exposures and intraperitoneal injections of methyl n-amyl ketone on multiple fixed-ratio, fixed-interval response rates in rats. Toxicol. Appl. Pharmacol. 1979, 49:407-416.
5. Neurobehavioural Toxicology 1987, Arnold, London. Z. Annau (Ed.).
6. Arezzo J.C., Simson R., Brennan N.E. Evoked potentials in the assessment of neurotoxicity in humans. Neurobehav. Toxicol. Teratol. 1985, 7:299-304.
7. Atchison W.D. Effects of neurotoxicants on synaptic transmission. Lessons learned from electrophysiological studies. Neurotoxicol. Teratol. 1988, 10:393-416.
8. Barrett D.S., Oehme F.W., Kruckenberg S.M. A review of organophosphorus ester-induced delayed neurotoxicity. Vet. Hum. Toxicol. 1985, 27:22-37.
9. Bischoff A. The ultrastructure of tri-ortho-cresyl phosphate poisoning. I. Studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropathol. 1967, 9:159-174.
10. Bischoff A. The ultrastructure of tri-ortho-cresyl phosphate poisoning in the chicken. II. Studies on spinal cord alterations. Acta Neuropathol. 1970, 15:142-155.
11. Bondy S.C. The biochemical evaluation of neurotoxic damage. Fundam. Appl. Toxicol. 1986, 6:208-216.
12. Brock T.O., O'Callaghan J.P. Quantitative changes in the synaptic vesicle proteins synapsin 1 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system. J. Neurosci. 1987, 7:931-942.
13. Broxup B., Robinson K., Losos G., Beyrouty P. Correlation between behavioral and pathological changes in the evaluation of neurotoxicity. Toxicol. Appl. Pharmacol. 1989, 101:510-520.
14. Carrera V., Diaz-Alejo N., Sogorb J.L., Vicedo J.L., Vilanova E. In vivo inhibition by mipafox of soluble and particulate forms of organophosphorus neuropathy target esterase (NTE) in hen sciatic nerve. Toxicol. Lett. 1994, 71:47-51.
15. Cavanagh J.B. The significance of the "dying back" process in experimental and human neurological disease. Int. Rev. Exp. Pathol. 1964, 3:219-267.
16. Cavanagh J.B. Peripheral nerve changes in ortho cresyl phosphate poisoning in the cat. J. Pathol. Bacteriol. 1964, 87:365-383.
17. Christoph G.R., Kelly D.P., Krivanek N. Acute inhalation exposure to cyclohexane and schedule-controlled operant performance in rats: comparison to d-amphetamine and chlorpromazine. Drug Chem. Toxicol. 2000, 23:539-553.
18. Cory-Slechta D.A. Behavioral measures of neurotoxicity. Neurotoxicology 1989, 10:271-296.
19. Cory-Slechta D.A., Bissen S.T., Young A.M., Thompson T. Chronic postweaning lead exposure and response duration performance. Toxicol. Appl. Pharmacol. 1981, 60:78-84.
20. Costa L.G. Interactions of neurotoxicants with neurotransmitter systems. Toxicology 1988, 49:359-366.
21. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 1941, 72:74-79.
22. De Groot D.M.G., Bos-Kuijpers M.H.M., Kaufmann W.S.H., Lammers J.H.C.M., O'Callaghan J.P., Pakkenberg B., Pelgrim M.T.M., Waalkens-Berendsen I.D.H., Waanders M.M., Gundersen H.J. Regulatory developmental neurotoxicity testing: a model study focusing on conventional neuropathology endpoints and other perspectives. Environ. Toxicol. Pharmacol. 2005, 19:745-755.
23. De Groot D.M.G., Hartgring S., van de Horst L., Moerkens M., Otto M., Bos-Kuijpers M.H.M., Kaufmann W.S.H., Lammers J.H.C.M., O'Callaghan J.P., Waalkens-Berendsen I.D.H., Pakkenberg B., Gundersen H.J. 2D and 3D assessment of neuropathology in rat brain after prenatal exposure to methylazoxymethanol, a model for developmental neurotoxicity. Reprod. Toxicol. 2005, 20:417-432.
24. De Jesus C.P.V., Tocofighi J., Snyder D.R. Sural nerve conduction study in the rat: a new technique for studying experimental neuropathies. Muscle Nerve 1978, 1:162-167.
25. Devlin R.J., Henry J.A. Clinical review: major consequences of illicit drug consumption. Crit. Care 2008, 12:202-208.
26. Dick F.D. Solvent neurotoxicity. Occup. Environ. Med. 2006, 63:221-226.
27. Dyer R.S. The use of sensory evoked potentials in toxicology. Fundam. Appl. Toxicol. 1985, 5:24-40.
28. Edwards P.M., Parker V.H. A simple, sensitive and objective method for early assessment of acrylamide neuropathy in rats. Toxicol. Appl. Pharmacol. 1977, 40:589-591.
29. Ehrich M., Jortner B.S., Padilla S. Comparison of the relative inhibition of acetylcholinesterase and neuropathy esterase in rats and hens given cholinesterase inhibitors. Fundam. Appl. Toxicol. 1995, 24:94-101.
30. Ekino S., Sus M., Ninomiya T., Kitamura T. Minamata disease revisited: and update on the acute and chronic manifestations of methyl mercury poisoning. J. Neurological Sci. 2007, 262:133-144.
31. Ellman G., Courtney K., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
32. Evaluation of the Neurotoxic Potential of Chemicals 1992, European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Monograph No. 18, ECETC, Brussels.
33. Fix A.S., Garman R.H. Practical aspects of neuropathology: A technical guide for working with the nervous system. Toxicol. Pathol. 2000, 28:122-131.
34. Fix A.S., Ross J.F., Stitzel S.R., Switzer R.C. Integrated evaluation of central nervous system lesions: stains for neurons, astrocytes, and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex. Toxicol. Pathol. 1996, 24:291-304.
35. Fullerton P.M., Barnes J.M. Peripheral neuropathy in rats produced by acrylamide. Br. J. Ind. Med. 1966, 23:210-221.
36. Garman A.H. Artefacts in routinely immersion-fixed nervous tissue. Toxicol. Pathol. 1990, 18:149-153.
37. Goonetilleke A., Harris J.B. Neurological problems caused by envenoming bites and stings, and the consumption of poisonous seafood. Medical Neurotoxicology 1999, 111-125. Arnold, London. P.G. Blain, J.B. Harris (Eds.).
38. Haggerty G.C. Development of tier I neurobehavioral testing capabilities for incorporation into pivotal rodent safety assessment studies. J. Am. Coll. Toxicol 1989, 8:53-69.
39. Harper C. The neurotoxicity of alcohol. Hum. Exp. Toxicol. 2007, 26:251-257.
40. Holson R.R., Freshwater L., Maurissen J.P.J., Moser V.C., Phang W. Statistical issues and techniques appropriate for developmental neurotoxicity testing. A report from the ILSI Risk Science Institute Expert Panel on neurodevelopmental endpoints. Neurotoxicol. Teratol. 2008, 30:326-348.
41. International Life Sciences Institute (2003). "Principles and Practices for Direct Dosing of Pre-Weaning Mammals in Toxicity Testing and Research" (T. Zoetis and I. Wallis, eds.). ILSI Press, Washington, DC.
42. Johnson B.L. Electrophysiological methods in neurotoxicity testing. Experimental and Clinical Neurotoxicology 1980, 726-742. Williams & Wilkins, Baltimore. P.S. Spencer, H.H. Schaumburg (Eds.).
43. Johnson C.D., Russell R.L. A rapid, simple, radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 1975, 64:229-238.
44. Johnson M.K. The delayed neuropathy caused by some organophosphorus esters: mechanism and challenge. Crit. Rev. Toxicol. 1975, 3:289-316.
45. Johnson M.K. Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch. Toxicol. 1977, 37:113-115.
46. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. Rev. Biochem. Toxicol 1982, 4:141-212.
47. Kayyali U.S., Moore T., Randall J.C., Richardson R.J. Neurotoxic esterase (NTE) assay: optimized conditions based on detergent-induced shifts in the phenol/4-aminoantipyrine chromophore spectrum. J. Anal. Toxicol. 1991, 15:86-89.
48. Kerkut G.A., Heal H.V. Electrophysiology in Isolated Mammalian CNS Preparations 1981, Academic Press, London.
49. Krinke G. Neuropathological screening in rodent and other species. J. Am. Coll. Toxicol. 1989, 8:141-146.
50. Krinke G., Hess R. The value of the fluorescence histochemistry of biogenic amines in neurotoxicology. Histochem. J. 1981, 13:849-865.
51. Krinke G.J., Vidotto N., Weber E. Teased-fiber technique for peripheral myelinated nerves: methodology and interpretation. Toxicol. Pathol. 2000, 28:113-121.
52. Krinke G.J., Classen W., Vidotto N., Suter E., Wurmlin C.H. Detecting necrotic neurons with Fluoro-Jade stain. Exp. Toxicol. Pathol. 2001, 53:365-372.
53. Leswing R.J., Ribelin W.E. Physiologic and pathologic changes in acrylamide neuropathy. Arch. Int. Environ. Health 1969, 18:22.
54. Lotti M. Clinical toxicology of anticholinesterase agents in humans. Handbook of Pesticide Toxicology 2001, Vol. 2:1043-1085. Academic Press, San Diego. 2nd ed. R.I. Krieger (Ed.).
55. Lotti M., Moretto A. Organophosphate-induced delayed polyneuropathy. Toxicol. Rev. 2005, 24:37-49.
56. Mattsson J.L., Albee R.R. Sensory evoked potentials in neurotoxicology. Neurotoxicol. Teratol. 1988, 10:435-443.
57. Mattsson J.L., Albee R.R., Eisenbrandt D.L. Neurological approach to neurotoxicological evaluation in laboratory animals. J. Am. Coll. Toxicol. 1989, 8:271-286.
58. Mattsson J.L., Eisenbrandt D.L., Albee R.R. Screening for neurotoxicity: complementarity of functional and morphological techniques. Toxicol. Pathol. 1990, 18:115-127.
59. Maurissen J.P. Neurobehavioral methods in the evaluation of sensory functions. Neurotoxicology: Approaches and Methods 1995, 239-264. Academic Press, New York. L.W. Chang, W. Slikker (Eds.).
60. Maurissen J.P. A few considerations in the design and analysis of experiments in neurotoxicology. Toxicol. Lett. 1995, 82/83:187-190.
61. McDaniel K.L., Moser V.C. Utility of a neurobehavioral screening battery for differentiating the effects of two pyrethroids, permethrin and cypermethrin. Neurotoxicol. Teratol. 1993, 15:71-83.
62. McMartin, D. N., O'Donoghue, J. L., Morrissey, R., and Fix, A. S. (1997). Non-proliferative lesions of the nervous system in rats. In "Guides for Toxicologic Pathology." STP/ARP/AFIP, Washington, DC.
63. Meyer O.A., Tilson H.A., Byrd W.C., Riley M.T. A method for the routine assessment of fore- and hind-limb grip strength of rats and mice. Neurobehav. Toxicol. 1979, 1:233-236.
64. Mitchell C.L., Tilson H.A. Behavioral toxicology in risk assessment: problems and research needs. Crit. Rev. Toxicol. 1982, 10:265-274.
65. Mohr U., Dungworth D.L., Capen C.C. Pathobiology of the Aging Rat 1994, Vol. 2. ILSI Press, Washington, DC.
66. Moretto A., Capodicasa E., Peraica M., Lotti M. Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks. Biochem. Pharmacol. 1991, 41:1497-1504.
67. Moser V.C., MacPhail R.C. Differential effects of formamidine pesticides on fixed-interval behavior in rats. Toxicol. Appl. Pharmacol. 1986, 84:315-324.
68. Moser V.C., MacPhail R.C. Comparative sensitivity of neurobehavioral tests for chemical screening. Neurotoxicology 1990, 11:335-344.
69. Moser V.C., McCormick J.P., Creason J.P., MacPhail R.C. Comparison of chlordimeform and carbaryl using a functional observation battery. Fundam. Appl. Toxicol. 1988, 11:189-206.
70. Muller K.E., Barton C.N., Benignus V.N. Recommendations for appropriate statistical practice in toxicological experiments. Neurotoxicology 1984, 5:113-125.
71. O'Brien R.D. Toxic Phosphorus Esters 1960, Academic Press, New York.
72. O'Brien R.D. Insecticides, Action and Metabolism 1967, Academic Press, New York.
73. O'Callaghan J.P. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. Neurotoxicol. Teratol. 1988, 10:445-452.
74. O'Callaghan J.P., Miller D.B. Acute exposure of the neonatal rat to triethyltin results in persistent changes in neurotypic and gliotypic proteins. J. Pharmacol. Exp. Ther. 1988, 244:368-378.
75. O'Donoghue J.L. Screening for neurotoxicity using a neurologically based examination and neuropathology. J. Am. Coll. Toxicol 1989, 8:97-115.
76. Neurotoxicity: Identifying and Controlling Poisons of the Nervous System 1990, Office of Technology Assessment, OTA-BA-436, U.S. Congress, Office of Technology Assessment, U.S. Government Printing Office, Washington, DC.
77. OECD Series on Testing an Assessment: Number 20. Guidance Document for Neurotoxicity Testing 2004, Organization for Economic Co-operation and Development (OECD), OECD, Paris.
78. Prineas J. The pathogenesis of dying-back polyneuropathies: Part I. An ultrastructural study of experimental triorthocresyl phosphate intoxication in the cat. J. Neuropathol. Exp. Neurol. 1969, 28:571.
79. Prockop L.D., Chichkova R.I. Carbon monoxide intoxication: an updated review. J. Neurol. Sci. 2007, 262:122-130.
80. Rebert C.S. Multisensory evoked potentials in experimental and applied neurotoxicology. Neurobehav. Toxicol. Teratol. 1983, 5:659-671.
81. Roberts N.L., Fairley C., Phillips C. Screening acute delayed and subchronic neurotoxicity studies in the hen: measurement ands and evaluations of clinical signs following administration of TOCP. Neurotoxicology 1983, 4:263-270.
82. Rowan M.J. Central nervous system toxicity evaluation in vitro: neurophysiological approach. Neurotoxicology 1985, Dekker, New York. K. Blum, L. Manzo (Eds.).
83. Scallet A.C. Quantitative morphometry for neurotoxicity assessment. Neurotoxicology: Approaches and Methods 1995, 99-132. Academic Press, San Diego. L. Chang, W. Slikker (Eds.).
84. 1-iminodiproprionitrile. Fundam. Appl. Toxicol. 1991, 16:602-615.
85. Schultz R.L., Karlsson U. Fixation of the central nervous system for electron microscopy by aldehyde perfusion: II. Effect of osmolarity, pH of perfusate, and fixative concentration. J. Ultrastruct. Res. 1965, 12:187-206.
86. Schumed L.C., Hopkins K.J. Fluoro-Jade B: a high affinity tracer for the localization of neuronal degeneration. Brain Res. 2000, 874:123-130.
87. Seppalainen A.M. Applications of neurophysiologic methods in occupational medicine: a review. Scand. J. Work Environ. Health 1975, 1:1-14.
88. Sherratt H.S.A. Jamaican vomiting sickness. Handbook of Clinical Neurology: Intoxicants of the Nervous System: Part II 1995, Vol. 21:79-112. Elsevier, Amsterdam, (65). F.A. de Wolff (Ed.).
89. Silbergeld E.K. Neurochemical approaches to developing markers of neurotoxicity. Review of current status and evaluation of future prospects. Environ. Res. 1987, 63:274-286.
90. Slikker W., Acuff K., Boyes W.K., Chelonis J., Crofton K.M., Dearlove G.E., Li A., Moser V.C., Newland C., Rossi J., Schanz S., Sette W., Sheets L., Stanton M., Tyl S., Sobotka T.J. Behavioral test methods workshop. Neurotoxicol. Teratol. 2005, 27:417-427.
91. Sohmer H. Action potentials recorded with evoked potential techniques: modes and sites of generation. J. Basic Clin. Physiol. Pharmacol. 1991, 2:243-255.
92. Soliman S.A., Linder R., Farmer J., Curley A. Species susceptibility to delayed toxic neuropathy in relation to in vivo inhibition of neurotoxic esterase by neurotoxic organophosphorus esters. J. Toxicol. Environ. Health 1982, 9:189-197.
93. Spencer P.S., Schaumburg H.B. Central and peripheral distal axonopathy"The pathology of dying-back neuropathies. Progress in Neuropathology 1976, Vol. 3:253-295. Grune & Stratton, New York. H.M. Zimmerman (Ed.).
94. Spencer P.S., Schaumburg H.B. Pathobiology of neurotoxic axonal degeneration. Physiology and Pathobiology of Axons 1978, 265-282. Raven Press, New York. S.G. Waxman (Ed.).
95. Spencer P.S., Bischoff M.C., Schaumburg H.H. Neuropathological methods for the detection of neurotoxic disease. Experimental and Clinical Neurotoxicology 1980, 743-766. Williams & Wilkins, Baltimore. P.S. Spencer, H.H. Schaumburg (Eds.).
96. Sprague G.L., Sandvik L.L., Bickford A.A. Time course for neurotoxic esterase inhibition in hens given multiple diisopropyl fluorophosphate injections. Neurotoxicology 1981, 2:523-532.
97. Switzer R.C. Application of silver degeneration stains for neurotoxicity testing. Toxicol. Pathol. 2000, 28:70-83.
98. Tilson H.A. Behavioral indices of neurotoxicity. Toxicol. Pathol. 1990, 18:96-104.
99. Tilson H.A. Learning and memory. Nervous System and Behavioral Toxicology 1997, 379-390. Pergamon, New York. H.E. Lowndes, K.R. Reuhl (Eds.).
100. Tilson H.A., Harry G.J. Neurobehavioral toxicology. Neurotoxicology 1992, 527-571. CRC Press, Boca Raton, FL. M.B. Abou-Donia (Ed.).
101. Tilson H.A., Moser V.C. Comparison of screening approaches. Neurotoxicology 1992, 13:1-14.
102. Tormo N., Gimeno J.R., Sogorb M.A., Diaz-Alejo N., Vilaanoa E. Soluble and particulate organophosphorus neuropathy target esterase in brain and sciatic nerve of the hen, cat, rat and chick. J. Neurochem. 1993, 61:2164-2168.
103. Guidance on cholinesterase measures in DNT and related studies 2001, U.S. Environmental Protection Agency (EPA), October 29, 2001, U.S. EPA, Washington, DC.
104. Walsh T.J., Chrobak J.J. The use of the radial arm maze in neurotoxicology. Physiol. Behav. 1987, 40:799-803.
105. Wilson B.W., Padilla S., Henderson J.D., Brimijoin S., Dass P.D., Elliot G., Jaeger B., Lanz D., Pearson R., Spies R. Factors in standardizing automated cholinesterase assays. J. Toxicol. Environ. Health 1996, 48:187-195.
106. Winneke G. Cross species extrapolation in neurotoxicology: neurophysiological and neurobehavioral aspects. Neurotoxicology 1992, 13:15-26.
107. International Programme on Chemical Safety. Environmental Health Criteria 60. Principles and Methods for the Assessment of Neurotoxicity Associated with Exposure to Chemicals 1986, World Health Organization (WHO), WHO, Geneva.
108. International Programme on Chemical Safety. Environmental Health Criteria 223. Neurotoxicity Risk Assessment for Human health: Principles and Approaches 2001, World Health Organization (WHO), WHO, Geneva.
109. Zech R., Chemnitius J.M. Neurotoxicant sensitive esterase: enzymology and pathophysiology of organophosphorus ester-induced delayed neuropathy. Prog. Neurobiol 1987, 29:193-218.
110. Zoetis, Wallis, & International Life Sciences Institute (2003).